Starpharma – drug delivery deal with Astra Zeneca

starpharma
(Left to right) Professor Ben Boyd, Chris Porter, and Dr Lisa Kaminskas

A long standing collaboration between MIPS scientists and the Melbourne-based biotechnology company Starpharma reached a significant commercialisation milestone when Starpharma signed a major licencing deal with the global pharmaceutical company Astra Zeneca . MIPS scientists have worked with Starpharma for over 10 years and are co-inventors on some of Starpharma's DEP® drug delivery patents. This platform improves delivery of anti-cancer agents to tumour sites, and reduces toxicities often seen during chemotherapy.

This is another example of the power of deep and enduring academic-industrial collaborations within the Australian biotechnology ecosystem – focused on translation of science in areas of unmet medical need and highlights Monash's commitment to nanoscience and progress towards the development of  next  generation  nanomedicines.

See related news story.

Back to Success stories